Home Spirometry in Children with Cystic Fibrosis

Ariel Berlinski1,2, Pamela Leisenring2, Lauren Willis2

  • 1Division of Pulmonology and Sleep Medicine, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.

Insights

Implementing home spirometry for pediatric patients shows promising results. This program helps manage respiratory conditions by providing reliable home-based lung function testing, crucial for patient care.

Area of Science:

  • Pulmonary Medicine
  • Pediatric Respiratory Care
  • Medical Device Implementation

Background:

  • Home spirometry offers a convenient alternative to clinic visits for monitoring lung function in pediatric patients.
  • Accurate and reliable home-based spirometry data is essential for effective management of chronic respiratory diseases in children.
  • Variability in spirometry measurements can impact clinical decision-making.

Purpose of the Study:

  • To report the implementation and initial outcomes of a pediatric home spirometry program.
  • To assess the feasibility and quality of home-based spirometry in a pediatric population.
  • To understand the variability and differences in spirometry measurements obtained through different methods.

Main Methods:

  • A respiratory therapist provided virtual or in-person initiation visits with coached spirometry sessions.
  • Families performed daily uncoached spirometry sessions for five days at home.
  • Quality assurance was conducted, and data from home spirometry were compared to clinic spirometry.

Main Results:

  • The program enrolled 52 subjects, with 34 completing at least three uncoached sessions.
  • Median coefficients of variation for uncoached maneuvers were 3.5% for FEV1%.
  • Differences between coached and uncoached home spirometry, and between home and clinic spirometry, were quantified.

Conclusions:

  • Pediatric home spirometry programs can be successfully implemented.
  • Understanding the variability of uncoached home spirometry is crucial for clinical application.
  • Home spirometry, when properly implemented, can be a valuable tool in managing pediatric respiratory conditions, including cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
208
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
409
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
320
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
265
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
585